Prentiss Smith & Co’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-722
| Closed | -$117K | – | 204 |
|
|
2018
Q3 | $117K | Hold |
722
| – | – | 0.07% | 79 |
|
|
2018
Q2 | $95K | Sell |
722
-3,166
| -81% | -$417K | 0.06% | 87 |
|
|
2018
Q1 | $288K | Buy |
3,888
+312
| +9% | +$23.1K | 0.15% | 67 |
|
|
2017
Q4 | $199K | Sell |
3,576
-312
| -8% | -$17.4K | 0.1% | 72 |
|
|
2017
Q3 | $176K | Buy |
3,888
+312
| +9% | +$14.1K | 0.1% | 65 |
|
|
2017
Q2 | $121K | Buy |
3,576
+3,166
| +772% | +$107K | 0.06% | 83 |
|
|
2017
Q1 | $12K | Hold |
410
| – | – | 0.01% | 186 |
|
|
2016
Q4 | $11K | Hold |
410
| – | – | 0.01% | 198 |
|
|
2016
Q3 | $25K | Hold |
410
| – | – | 0.01% | 161 |
|
|
2016
Q2 | $8K | Hold |
410
| – | – | ﹤0.01% | 223 |
|
|
2016
Q1 | $8K | Buy |
+410
| New | +$8K | ﹤0.01% | 248 |
|